TITLE

Amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension

PUB. DATE
March 2006
SOURCE
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p32
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study which revealed that amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension. Outcomes included all-cause mortality, total stroke, all coronary events, total cardiovascular events and procedures, and cardiovascular (CV) mortality. Amlodipine plus perindopril was better at reducing the rates of all-cause mortality, total stroke, all coronary events, total CV events and procedures and CV mortality.
ACCESSION #
20297584

 

Related Articles

  • COMMENTARY: Amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension. Zarnke, Kelly B. // ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p32 

    The article focuses on a study which revealed that amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension. The clinical trial compared a calcium blocker with a beta-blocker in high-risk patients with hypertension. Many...

  • ACE/CCB or ACE/HCTZ for HTN: Which is better? Kuritzky, Louis // Clinical Oncology Alert;Feb2009 Supplement, Vol. 14 Issue 2, p4 

    The article discusses research being done on outcomes in high-risk hypertensive (HTN) patients. It references a study by K. Jamerson et al published in a 2008 issue of the "New England Journal of Medicine." Subjects in this study are considered high-risk due to substantial comorbidity. Their...

  • Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy. Neldam, Steen; Dingliang Zhu; Schumacher, Helmut // International Journal of Hypertension;2013, p1 

    Hypertensive patients unable to reach blood pressure (BP) targets with antihypertensive monotherapy may be switched to a combination of two medications with complementary modes of action for improved treatment response. This post hoc analysis pools data from 2812 patients, 1891 of whom were not...

  • The TRINITY Study: distribution of systolic blood pressure reductions. Sugimoto, Danny H.; Chrysant, Steven G.; Melino, Michael; Fernandez, Victor; Lee, James; Heyrman, Reinilde // Integrated Blood Pressure Control;2013, Vol. 6, p89 

    Background: Elevated systolic blood pressure is more difficult to control than elevated diastolic blood pressure. The objective of this prespecified analysis of the Triple Therapy with Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide in Hypertensive Patients Study (TRINITY) was to...

  • Pharmacokinetics, Tolerability, and Safety of the Single Oral Administration of AGSAV301 vs Exforge: A Randomized Crossover Study of Healthy Male Volunteers. Choi, Hee; Kim, Yo; Kim, Mi; Noh, Yook-Hwan; Lee, Shi; Bae, Kyun-Seop; Lim, Hyeong-Seok // American Journal of Cardiovascular Drugs;Feb2014, Vol. 14 Issue 1, p63 

    Background and Objective: Valsartan, an angiotensin receptor blocker, is often used with calcium channel blockers (CCBs) such as amlodipine to control hypertension. Recently, the fixed-dose combination (FDC) of amlodipine 10 mg/valsartan 160 mg (Exforge) was approved. Amlodipine is a racemic...

  • Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension. Deeks, Emma D. // American Journal of Cardiovascular Drugs;2009, Vol. 9 Issue 6, p411 

    â–´ Amlodipine/valsartan/hydrochlorothiazide (HCTZ) is a fixed-dose combination of the well established antihypertensive agents amlodipine (a calcium channel antagonist), valsartan (an angiotensin II receptor antagonist), and HCTZ (a thiazide diuretic). â–´ In patients with moderate or...

  • Aliskiren/Amlodipine vs. Aliskiren/Hydrochlorothiazide in Hypertension: Indirect Meta-Analysis of Trials Comparing the Two Combinations vs. Monotherapy. Liu, Yang; Yan, Rui; Song, Anqi; Niu, Xiaolin; Cao, Chunhui; Wei, Jin; Dong, Xin; Gao, Dengfeng // American Journal of Hypertension;Feb2014, Vol. 27 Issue 2, p268 

    BACKGROUND Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when combined with amlodipine or hydrochlorothiazide (HCTZ). However, the efficacy and tolerability of the 2 combinations are unclear. We performed a meta-analysis of...

  • Successful management of mixed amlodipine and atenolol overdose. Thunga, Girish; Patel, Hiren; Robert, Neethu; Nair, Sreedharan; Kunhikatta, Vijayanarayana; Acharya, Raviraj // Journal of Pharmacy Practice & Research;Jun2013, Vol. 43 Issue 2, p163 

    A letter to the editor is presented which is concerned with a 28 year old female patient whose mixed amlodipine and atenolol overdose was managed successfully by medical personnel.

  • Q / Which combination drug therapies are most effective for hypertension? Crawford, Paul; Dy, David; Carney, Misty; Crownover, Brian K. // Journal of Family Practice;Nov2011, Vol. 60 Issue 11, p684 

    The article provides an answer to a question of which are the most effective combination drug therapies for hypertension.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics